COLL vs V
Collegium Pharmaceutical Inc (COLL) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the COLL and V stock pages for the full models.
Not investment advice.